A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 769-775

  Wang, Furu ^a   Hu, Zhibin ^a,b,c   Yang, Rongxi ^b,c   Tang, Jinhai ^d   Liu, Yao ^a   Hemminki, Kari ^b,e   Sutter, Christian ^c   Wappenschmidt, Barbara ^f   Niederacher, Dieter ^g   Arnold, Norbert ^h   Meindl, Alfons ⁱ   Bartram, Claus R ^c   Schmutzler, Rita K ^f   Burwinkel, Barbara ^b,c   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d JIANGSU CANCER HOSPITAL   (China)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF COLOGNE   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Breast cancer; miRNAs; Molecular epidemiology; NPAS2; SNPs

Indexed keywords

CIRCADIAN RHYTHM SIGNALING PROTEIN; MICRORNA; MICRORNA 17 5P; MICRORNA 20B; MICRORNA 519E; NEURONAL PAS DOMAIN PROTEIN 2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CELL LINE; CHINESE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; GERMANY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; CIRCADIAN RHYTHM; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HUMANS; MICRORNAS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79958278160     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1157-8     Document Type: Article

References (31)

1. JA Lie J Roessink K Kjaerheim 2006 Breast cancer and night work among Norwegian nurses Cancer Causes Control 17 39 44 16411051 10.1007/s10552-005- 3639-2 (Pubitemid 43083668)
2. S Davis DK Mirick RG Stevens 2001 Night shift work, light at night, and risk of breast cancer J Natl Cancer Inst 93 1557 1562 11604479 10.1093/jnci/93.20.1557 1:STN:280:DC%2BD3MrlvVWqtg%3D%3D (Pubitemid 32998485)
3. ES Schernhammer F Laden FE Speizer WC Willett DJ Hunter I Kawachi GA Colditz 2001 Rotating night shifts and risk of breast cancer in women participating in the nurses' health study J Natl Cancer Inst 93 1563 1568 11604480 10.1093/jnci/93.20.1563 1:STN:280:DC%2BD3MrlvVWqtw%3D%3D (Pubitemid 32998486)
4. RG Stevens 2005 Circadian disruption and breast cancer: from melatonin to clock genes Epidemiology 16 254 258 15703542 10.1097/01.ede.0000152525.21924.54 (Pubitemid 40314419)
5. L Fu CC Lee 2003 The circadian clock: pacemaker and tumour suppressor Nat Rev Cancer 3 350 361 12724733 10.1038/nrc1072 1:CAS:528:DC%2BD3sXjtlals78%3D (Pubitemid 37328855)
6. Y Zhu RG Stevens D Leaderer A Hoffman T Holford Y Zhang HN Brown T Zheng 2008 Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk Breast Cancer Res Treat 107 421 425 17453337 10.1007/s10549-007-9565-0 1:CAS:528:DC%2BD1cXht1SgsbY%3D (Pubitemid 351172117)
7. MH Vitaterna DP King AM Chang JM Kornhauser PL Lowrey JD McDonald WF Dove LH Pinto FW Turek JS Takahashi 1994 Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior Science 264 719 725 8171325 10.1126/science.8171325 1:CAS:528:DyaK2cXktVagsLs%3D (Pubitemid 24185884)
8. MK Bunger LD Wilsbacher SM Moran C Clendenin LA Radcliffe JB Hogenesch MC Simon JS Takahashi CA Bradfield 2000 Mop3 is an essential component of the master circadian pacemaker in mammals Cell 103 1009 1017 11163178 10.1016/S0092-8674(00)00205-1 1:CAS:528:DC%2BD3MXit1WrtQ%3D%3D (Pubitemid 32037390)
9. CA Dudley C Erbel-Sieler SJ Estill M Reick P Franken S Pitts SL McKnight 2003 Altered patterns of sleep and behavioral adaptability in NPAS2-deficient mice Science 301 379 383 12843397 10.1126/science.1082795 1:CAS:528: DC%2BD3sXls1yhu7g%3D (Pubitemid 36877075)
10. M Reick JA Garcia C Dudley SL McKnight 2001 NPAS2: an analog of clock operative in the mammalian forebrain Science 293 506 509 11441147 10.1126/science.1060699 1:CAS:528:DC%2BD3MXlsFGjt7Y%3D (Pubitemid 32679079)
11. L Fu H Pelicano J Liu P Huang C Lee 2002 The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo Cell 111 41 50 12372299 10.1016/S0092-8674(02)00961-3 1:CAS:528:DC%2BD38XnvFCrtbw%3D
12. M Chen-Goodspeed CC Lee 2007 Tumor suppression and circadian function J Biol Rhythms 22 291 298 17660446 10.1177/0748730407303387 1:CAS:528: DC%2BD2sXpsFajtLw%3D (Pubitemid 47077311)
13. AE Hoffman T Zheng Y Ba Y Zhu 2008 The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response Mol Cancer Res 6 1461 1468 18819933 10.1158/1541-7786.MCR-07-2094 1:CAS:528:DC%2BD1cXhtFKhs7jE
14. CH Yi T Zheng D Leaderer A Hoffman Y Zhu 2009 Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis Cancer Lett 284 149 156 19457610 10.1016/j.canlet.2009.04. 017 1:CAS:528:DC%2BD1MXhtV2lt73E
15. C Yi L Mu IA de la Longrais O Sochirca R Arisio H Yu AE Hoffman Y Zhu D Katsaro 2009 The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer Breast Cancer Res Treat 120 3 663 669 19649706 10.1007/s10549-009-0484-0
16. V Ambros X Chen 2007 The regulation of genes and genomes by small RNAs Development 134 1635 1641 17409118 10.1242/dev.002006 1:CAS:528: DC%2BD2sXmt1aitbY%3D (Pubitemid 46796561)
17. TM Rana 2007 Illuminating the silence: understanding the structure and function of small RNAs Nat Rev Mol Cell Biol 8 1 23 36 17183358 10.1038/nrm2085 1:CAS:528:DC%2BD28XhtlCjt7bE (Pubitemid 46012012)
18. Z Hu J Liang Z Wang T Tian X Zhou J Chen R Miao Y Wang X Wang H Shen 2009 Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women Hum Mutat 30 79 84 18634034 10.1002/humu.20837 1:CAS:528:DC%2BD1MXivFygsbw%3D
19. S Tchatchou A Jung K Hemminki, et al. 2009 A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women Carcinogenesis 30 59 64 19028706 10.1093/carcin/bgn253 1:CAS:528:DC%2BD1MXhtVaqu7s%3D
20. J Liang P Chen Z Hu X Zhou L Chen M Li Y Wang J Tang H Wang H Shen 2008 Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women Carcinogenesis 29 2341 2346 18845558 10.1093/carcin/bgn235 1:CAS:528:DC%2BD1cXhsVOgsLnL
21. R Yang B Frank K Hemminki, et al. 2008 SNPs in ultraconserved elements and familial breast cancer risk Carcinogenesis 29 351 355 18174240 10.1093/carcin/bgm290 1:CAS:528:DC%2BD1cXislKhsbk%3D (Pubitemid 351359674)
22. J Hansen 2001 Increased breast cancer risk among women who work predominantly at night Epidemiology 12 74 77 11138824 10.1097/00001648- 200101000-00013 1:STN:280:DC%2BD3M7hsFKjtg%3D%3D (Pubitemid 32006465)
23. RG Stevens MS Rea 2001 Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer Cancer Causes Control 12 279 287 11405333 10.1023/A:1011237000609 1:STN:280: DC%2BD3Mzkt1Ogsw%3D%3D (Pubitemid 32515375)
24. Y Zhu D Leaderer C Guss, et al. 2007 Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma Int J Cancer 120 432 435 17096334 10.1002/ijc.22321 1:CAS:528:DC%2BD28XhtlGqsrnN (Pubitemid 44956857)
25. Y Hayashita H Osada Y Tatematsu H Yamada K Yanagisawa S Tomida Y Yatabe K Kawahara Y Sekido T Takahashi 2005 A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation Cancer Res 65 9628 9632 16266980 10.1158/0008-5472.CAN-05-2352 1:CAS:528: DC%2BD2MXhtFKkt7jE (Pubitemid 41541436)
26. L He JM Thomson MT Hemann, et al. 2005 A microRNA polycistron as a potential human oncogene Nature 435 828 833 15944707 10.1038/nature03552 1:CAS:528:DC%2BD2MXkvVGgs70%3D (Pubitemid 40839734)
27. A Hossain MT Kuo GF Saunders 2006 Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA Mol Cell Biol 26 8191 8201 16940181 10.1128/MCB.00242-06 1:CAS:528:DC%2BD28XhtFemur3F (Pubitemid 44631015)
28. Z Yu C Wang M Wang, et al. 2008 A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation J Cell Biol 182 509 517 18695042 10.1083/jcb.200801079 1:CAS:528:DC%2BD1cXpvFKlt7o%3D
29. J Lu G Getz EA Miska, et al. 2005 MicroRNA expression profiles classify human cancers Nature 435 834 838 15944708 10.1038/nature03702 1:CAS:528:DC%2BD2MXkvVGgsLc%3D (Pubitemid 40839735)
30. L Zhang J Huang N Yang, et al. 2006 MicroRNAs exhibit high frequency genomic alterations in human cancer Proc Natl Acad Sci USA 103 9136 9141 16754881 10.1073/pnas.0508889103 1:CAS:528:DC%2BD28XmsVWjsb8%3D (Pubitemid 43902545)
31. KA O'Donnell EA Wentzel KI Zeller CV Dang JT Mendell 2005 c-Myc-regulated microRNAs modulate E2F1 expression Nature 435 839 843 15944709 10.1038/nature03677 (Pubitemid 40839736)